Grufity logoGrufity logo

RMD

232.90USD+3.56(+1.55%)Market Closed

ResMed Inc

Market Summary

USD232.90+3.56Market Closed
1.55%

RMD Alerts

RMD Stock Price

RSI Chart

Valuation

Market Cap

32.0B

Price/Earnings

40.74

Price/Sales

8.84

Price/Cashflow

69.42

MarketCap/EBT

33.25

Price/Sales

Profitability

EBT Margin

26.58%

Return on Equity

22.9%

Return on Assets

15.19%

Fundamentals

Revenue

Revenue (TTM)

3.6B

Revenue Y/Y

5.12%

Revenue Q/Q

3.89%

Earnings

Earnings (TTM)

786.3M

Earnings Y/Y

3.37%

Earnings Q/Q

7.9%

Price Action

52 Week Range

188.66266.67
(Low)(High)

Last 7 days

1.3%

Last 30 days

7.1%

Last 90 days

8.1%

Trailing 12 Months

-8.3%

Financial Health

Current Ratio

2.94

Debt/Equity

0.23

Debt/Cashflow

0.59

Investor Care

Dividend Yield

0.78%

Dividend/Share (TTM)

1.7

Shares Dilution (1Y)

0.52%

Diluted EPS (TTM)

5.35

Peers (Alternatives to ResMed)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
10.2T
429.9M
-11.88% 44.84%
185.5K
28.0K
144.70% 331.94%
86.7B
17.9B
14.69% -0.88%
41.71
4.92
7.67% 29.32%
86.3B
6.1B
15.30% -16.82%
62.6
14.1
11.47% -18.42%
67.1B
18.9B
10.69% 8.01%
38.21
3.25
-6.81% -14.96%
61.8B
12.3B
11.14% 17.68%
69.9
5.01
10.11% 51.89%
43.9B
5.4B
8.87% -30.30%
30.09
8.18
5.29% -1.25%
MID-CAP
6.7B
998.4M
15.24% 17.79%
44.21
6.87
6.04% -19.01%
6.4B
806.4M
33.98% -14.84%
-331.15
7.96
20.10% -221.96%
3.9B
380.1M
-8.48% 5.83%
-29.57
10.69
18.85% -63.58%
3.6B
790.7M
-16.73% -66.49%
-273.58
4.7
19.65% -412.22%
SMALL-CAP
1.6B
126.8M
26.44% 24.39%
-26.38
14.01
34.44% -10.05%
1.1B
291.9M
9.49% -7.06%
-6.57
3.67
52.45% -57.74%
1.0B
795.9M
17.05% -10.97%
-131.34
1.33
8.11% 182.50%
606.7M
236.2M
-6.64% -29.40%
-16.43
2.57
-8.79% -175.19%

Financials for ResMed

Income Statement (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Revenue1.3%3,6243,5783,5393,4443,349
Gross Profit1.7%2,0592,0241,9931,9491,907
Operating Expenses2.0%1,0451,0241,006973958
  S&GA Expenses2.3%757739726704688
  R&D Expenses1.3%257254249238231
Earnings Before Taxes0.3%963960962953927
Net Income0.9%786779779522500
Balance Sheet
(In Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Assets1.6%5,1785,0964,9054,7354,729
  Current Assets5.3%2,0341,9311,7041,5471,586
    Cash Equivalents-24.3%207274202194276
  Inventory16.3%865744665592507
  Net PPE-2.2%487498513478467
  Goodwill0.1%1,9391,9361,9461,9511,922
Liabilities0.6%1,7451,7351,6261,5891,703
  Current Liabilities0.5%693689667621624
.    Short Term Borrowings-0.1%1010121212
  Long Term Debt2.6%785765669668794
Shareholder's Equity2.1%3,4333,3613,2793,1463,026
  Retained Earnings4.0%3,7603,6143,4803,3633,222
  Additional Paid-In Capital1.2%1,7021,6821,6451,6291,644
Shares Outstanding0.0%146146146146146
Float-37,771----
Cashflow (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Cashflow From Operations31.4%461351498577527
  Share Based Compensation-0.6%6565666665
Cashflow From Investing-7.4%-246.85-229.92-222.75-231.87-178.23
Cashflow From Financing-105.1%-263.21-128.36-299.90-397.58-496.40
  Dividend Payments1.3%249245241236231

Risks

What is the probability of a big loss on RMD?

56.5%


Probability that ResMed stock will be more than 20% underwater in next one year

26.9%


Probability that ResMed stock will be more than 30% underwater in next one year.

0%


Probability that ResMed stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does RMD drawdown profile look like?

Y-axis is the maximum loss one would have experienced if ResMed was unfortunately bought at previous high price.

Returns

Cumulative Returns on RMD

20.8%


10-Year Cumulative Returns

23.6%


7-Year Cumulative Returns

23.8%


5-Year Cumulative Returns

16.8%


3-Year Cumulative Returns

What are the long-term rolling returns for RMD?

FIve years rolling returns for ResMed.

Which funds bought or sold RMD recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2022-11-29
Bridgefront Capital, LLC
-
-
-439,000
-
-%
2022-11-23
Toroso Investments, LLC
ADDED
4.77
56,000
671,000
0.03%
2022-11-23
Eagle Bay Advisors LLC
ADDED
15
807
5,000
-%
2022-11-22
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY
NEW
-
3,038,000
3,038,000
0.04%
2022-11-22
CVA Family Office, LLC
-
-
29,000
46,000
0.01%
2022-11-22
Seaport Global Advisors, LLC
-
-
35,000
388,000
1.58%
2022-11-22
Capital Impact Advisors, LLC
-
-
-96,000
406,000
0.40%
2022-11-21
FourThought Financial, LLC
-
-
11,000
15,000
-%
2022-11-21
ST GERMAIN D J CO INC
-
-
-
3,944,000
0.26%
2022-11-21
DEARBORN PARTNERS LLC
-
-
25,000
344,000
0.01%

1–10 of 47

Latest Funds Activity

Are funds buying RMD calls or puts?
Are funds bullish or bearish(Calls - Puts)?
No. of funds that own RMD

ResMed News

Simply Wall St

ResMed Inc. (NYSE:RMD) insiders sold US$2.9m worth of stock, possibly signalling a downtrend.9 hours ago

The Motley Fool Australia

RMD Fair Value

Recent SEC filings of ResMed

View All Filings
Date Filed Form Type Document
Nov 29, 2022
4
Insider Trading
Nov 23, 2022
4
Insider Trading
Nov 23, 2022
4
Insider Trading
Nov 23, 2022
4
Insider Trading
Nov 23, 2022
4
Insider Trading
Nov 23, 2022
4
Insider Trading
Nov 23, 2022
4
Insider Trading
Nov 22, 2022
4
Insider Trading
Nov 21, 2022
4
Insider Trading
Nov 18, 2022
4
Insider Trading

Latest Insider Trading transactions for RMD

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2022-11-28
PENDARVIS DAVID
GIFTED
-
-
-7,300
Chief Administrative Officer
2022-11-25
PENDARVIS DAVID
ACQUIRED
99,950.2
146.34
683
Chief Administrative Officer
2022-11-23
Sandercock Brett
ACQUIRED
-
-
14,577
Chief Financial Officer
2022-11-23
PENDARVIS DAVID
SOLD FOR TAXES
-1,550,830
224.4
-6,911
Chief Administrative Officer
2022-11-23
Ghoshal Kaushik
ACQUIRED
-
-
7,288
President, SaaS Business
2022-11-23
Farrell Michael J.
ACQUIRED
-
-
56,115
Chief Executive Officer
2022-11-23
Ghoshal Kaushik
SOLD FOR TAXES
-968,959
224.4
-4,318
President, SaaS Business
2022-11-23
Leong Justin
ACQUIRED
-
-
6,924
President, Asia Latin America
2022-11-23
Farrell Michael J.
SOLD FOR TAXES
-7,458,830
224.4
-33,239
Chief Executive Officer
2022-11-23
Douglas Robert Andrew
ACQUIRED
-
-
32,795
President and COO

1–10 of 50

RMD Income Statement

2022-09-30
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Net revenue$ 950,294$ 904,015
Cost of sales (exclusive of amortization shown separately below)403,110386,667
Amortization of acquired intangible assets6,37411,059
Total cost of sales409,484397,726
Gross profit540,810506,289
Operating Expenses  
Selling, general, and administrative193,933176,719
Research and development63,18859,950
Amortization of acquired intangible assets7,9507,707
Total operating expenses265,071244,376
Income from operations275,739261,913
Other income (loss), net:  
Interest (expense) income, net(7,134)(5,360)
Loss attributable to equity method investments (note 5)(2,028)(1,386)
Gain (loss) on equity investments (note 5)(3,280)5,612
Other, net(1,504)(1,991)
Total other income (loss), net(13,946)(3,125)
Income before income taxes261,793258,788
Income taxes51,31555,175
Net income$ 210,478$ 203,613
Basic earnings per share (dollars per share)$ 1.44$ 1.40
Diluted earnings per share (dollars per share)1.431.39
Dividend declared per share (dollars per share)$ 0.44$ 0.42
Basic shares outstanding (000's) (in shares)146,431145,680
Diluted shares outstanding (000's) (in shares)147,134146,860
Total Sleep and Respiratory Care  
Net revenue$ 844,443$ 806,499
Cost of sales (exclusive of amortization shown separately below)363,844349,681
Amortization of acquired intangible assets1,228900
Software as a Service  
Net revenue105,85197,516
Cost of sales (exclusive of amortization shown separately below)39,26636,986
Amortization of acquired intangible assets$ 5,146$ 10,159

RMD Balance Sheet

2022-09-30
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Sep. 30, 2022
Jun. 30, 2022
Current assets:  
Cash and cash equivalents$ 207,163$ 273,710
Accounts receivable, net of allowances of $23,867 and $23,259 at September 30, 2022 and June 30, 2022, respectively620,483575,950
Inventories (note 3)864,852743,910
Prepaid expenses and other current assets (note 3)341,199337,908
Total current assets2,033,6971,931,478
Non-current assets:  
Property, plant and equipment, net (note 3)487,376498,181
Operating lease right-of-use assets125,319132,314
Goodwill (note 4)1,938,8431,936,442
Other intangible assets, net (note 3)338,151345,944
Deferred income taxes80,74579,746
Prepaid taxes and other non-current assets173,429171,748
Total non-current assets3,143,8633,164,375
Total assets5,177,5605,095,853
Current liabilities:  
Accounts payable181,485159,245
Accrued expenses324,055344,722
Operating lease liabilities, current21,07621,856
Deferred revenue108,195108,667
Income taxes payable (note 6)47,94244,893
Short-term debt, net (note 8)9,9069,916
Total current liabilities692,659689,299
Non-current liabilities:  
Deferred revenue97,62095,455
Deferred income taxes11,8309,714
Operating lease liabilities, non-current114,214120,453
Other long-term liabilities5,8385,974
Long-term debt, net (note 8)785,436765,325
Long-term income taxes payable (note 6)37,07648,882
Total non-current liabilities1,052,0141,045,803
Total liabilities1,744,6731,735,102
Commitments and contingencies (note 10)
Stockholders’ equity:  
Preferred stock, $0.01 par value, 2,000,000 shares authorized; none issued00
Common stock, $0.004 par value, 350,000,000 shares authorized; 188,295,266 issued and 146,459,032 outstanding at September 30, 2022 and 188,246,955 issued and 146,410,721 outstanding at June 30, 2022586586
Additional paid-in capital1,701,9021,682,432
Retained earnings3,759,7833,613,736
Treasury stock, at cost, 41,836,234 shares at September 30, 2022 and June 30, 2022(1,623,256)(1,623,256)
Accumulated other comprehensive loss(406,128)(312,747)
Total stockholders’ equity3,432,8873,360,751
Total liabilities and stockholders’ equity$ 5,177,560$ 5,095,853